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Abstract: A novel thermosensitive local drug release system was prepared by incorporation of biocompatible 
nanoclay laponite into pluronic F127 solution and characterized by rheological measurements, zeta potential 
measurement and in vitro drug release measurement in the presence of lidocaine hydrochloride. All the systems 
transited from sol to gel with increase of temperature. The lower critical solution temperature (LCST) of the 
composite matrix changed little with increase in the mass of incorporated nanoclay, but the modulus increased 
with increase in the mass of incorporated nanoclay. Thein-vitrorelease experiments revealed that the novel 
system provided an extended duration of drugs compared to the pluronic F127 alone. This unique feature is 
attributed to the interaction of nanoclay laponite with lidocaine hydrochloride and increased modulus with 
incoporation of nanoclay laponite. The merits of the novel system, such as good cytocompatibility, 
thermosensitive properties, and improved sustained local release ability, make them a promising platform for the 
delivery of other drugs. 





    Controlled drug delivery systems that can release drugs in a predetermined rate and to optimize the 
therapeutic effects have become significant in recent years [1-4]. Among these thermo-sensitive systems that can 
be transformed from sol to gel in situ at certain temperature play a very important role because of the 
conveniently controllable adjustment of temperature [5-8]. They are liquid below room temperature and gel at 
body temperature. Hence they are easily injected and once they fill the proper cavity they become gel as they 
reach body temperature. Pluronic F127 is a commercial thermo-sensitive hydrogel, which have been widely used 
in drug delivery systems [9-11]. It exhibits reversible thermal gelation in aqueous solution at 
concentrations>20% (w/v).Drug delivery via F127 gel occurs by diffusion and dissolution of the gel at the 
administration site. The release profiles of several drugs delivered via F127 gels have been published [12-19]. 
These studies have also shown that the drug diffusion coefficient in the gel decreases as F127 content increases, 
coinciding with an increase in gel viscosity. This has led the authors to propose that drug release rates are 
determined by gel viscosity [20]. Many additives like salts [21], water-soluble polymers [22], and PCEP 
nanoparticles [23] can change the sol-gel transition temperature, gel viscosity, drug solubilisation of F127 
solutions. 
    In this study, we report the effects of nanoclay laponite on the release of lidocaine hydrochloride from 20% 
F127 gels.Laponite (LP) is a synthetic nanoclay that has a nanodisk structure (25 nm in diameter and 0.92 nm in 
thickness), and can be biodegraded into nontoxic products (Na+, Si(OH)4, Mg2+, Li+), very much similar to what 
happens with bioactive glasses (Na+, Si(OH)4, Ca2+, PO43−). The chemical structure of the LP crystals confer 
them a negatively charged surface and pH-dependent edge surface charges (positive at a pH lower than 9) [24]. 
Its unique structure, together with its good biocompatibility [25], and osteoinductivity[26], makes LP act as an 
ideal inorganic nanomaterial for biomedical applications [27]. Goncalves et al. studies revealed that through 
electrostatic interactions, DOX was able to form nanocomplexes with LP, which improved the bioactivity of the 
drug in cancer cells by overcoming drug resistance processes [28]. Wang et al. used laponite nanodisks as an 
efficient platform for Doxorubicin delivery to cancer cells [29]. Furthermore, LP has an ability to form strong 
interactions with hydrophobic molecules [30, 31], it is proposed that an amphiphilic block polymer can be used 
to form a protective coating on LP nanodisks, where the hydrophobic block will cover the surface of LP 
nanodisks working as an anchor, whereas the hydrophilic part will act as a stealth shell to maintain their stability 
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under physiological environment. Wang et al. prepared pH-sensitive drug delivery nanosystems using PEG-PLA 
copolymer for improving LP physiological stability [32]. F127 can also absorb to LP and improve the stability of 
LP system [33]. Lidocaine hydrochloride is a local anesthetic and selected as a model drug because its use is 
limited by the short duration of its effects.Herein, we present an elegant approach to preparing a new type of 
thermosensitive hybrid system based on pluronic F127 and nanoclay laponite with good cytocompatibility and 
stability, which are able to sustain local release of Lidocaine hydrochloride. 
 
2. Materials and methods 
2.1 Materials 
    Lidocaine hydrochloride (LC), Pluronic F127 (12,600Da, 70%w/w PEO), cellulose acetate dialysis tubes 
(Cutoff MW at-7000) and Dulbecco’s phosphate buffer saline (PBS, without Ca2+ and Mg2+) solution were 
purchased from Sigma-Aldrich, USA. The de-ionized water used was treated with Millipore-Q water purification 
system. Laponite RDS (LP) was friendly offered from Rockwood Additives Limited, UK. 
 
2.2 Sample preparation 
    All the samples were prepared on a weight basis using the cold method [34]. Concentrations of Pluronic 
polymer F127, LP and LC are expressed by weight percentage (% w/w). For the preparation of F127/LC sample, 
Pluronic polymer was dissolved in de-ionized (DI) water and stirred at 4 °C. The solution was then put into the 
refrigerator at 4 °C for 1~2 days until it became clear. Then LC was added to the solution, stirred at 4 °C until it 
was dissolved completely. In order to obtain a F127/LP/LC samples, we first dissolved LP in DI water while 
stirring for 24 h. In order to further exfoliate the LP, the solution was subsequently sonicated for 1 h. The LP 
solution was placed into an ice bath and the F127 polymer was added. In order to ensure that the polymer was 
completely dissolved, the entire solution was then refrigerated at 4 °C. LC was added at last. 
 
2.3 Characterizations 
    Rheological measurements were conducted on a TA AR-G2 rheometer using the system of coaxial cylinders 
(stator inner radius of 15.00 mm, rotor inner radius of 14.00 mm, cylinder immersed height of 42 mm). The 
concentric cylinder geometry was loaded with the polymer solutions at 4 °C, in order to ensure that they were in 
the liquid state. Temperature sweep measurements were performed from 4 °C to 45 °C at a constant heating rate 
of 1 °C/min. The storage modulus G’ and loss modulus G” were measured as a function of temperature at an 
angular frequency of 1 rad/s within a linear range of viscoelasticity. The frequency dependence of the complex 
modulus was determined between 0.01 and 100 rad/s. A thin layer of low-viscosity silicone oil was used to cover 
the free surface of the solution to prevent evaporation of solvent. 
    The hydrodynamic diameter and the surface charge of LP, LP/LC and LP/LC/F127 water solution were 
measured at room temperature using a Zetasizer Nano ZS (Malvern Instruments, UK).The hydrodynamic 
diameters were determined with a detection angle of 173°. Zeta potential measurements were performed with a 
detection angle of 17° and calculated using the Smoluchowsky model for aqueous suspensions. Before 
measurement, LP, LP/LC and LP/LC/F127 solutions prepared in 2.2 were diluted with 6 times water and 
sonicated (BRANSON 2510,100 W) for 15 min.  
    Ultraviolet-visible (UV-vis) spectroscopy was performed using a Lambda 25 UV-vis spectrometer 
(PerkinElmer25). Before measurement, LP/LC and LP/LC/F127 solutions prepared in 2.2 were dialyzed against 
UP water, for 12 h (the dialysis membrane had a molecular weight cutoffof 14 000 Da, Spectrum Laboratories, 
Inc.), to obtain the final products named as LP/LC and LP/LC/F127nanohybrids, respectively. Free LC, and LC-
loaded nanohybrids were dispersed in water before measurements. LP/F127 solution was also tested as controls. 
 
2.4 In vitro drug release 
    In vitro release response of LC was carried out in the USP eight stage dissolution rate test apparatus with the 
dialysis bag technique [35, 36]. Buffer solutions of pH 7.4 were used as dissolution medium. Amounts of LC, 
F127/LC, and LP/F127/LC, dispersed in 5 ml release medium in cellulose dialysis tubes (cutoff molecular mass 
of 7000) were immersed in 500 ml release medium. The temperature was maintained at 37 ±0.5 °C. The rotation 
frequency was kept at 100 rpm. Aliquots (5 ml) were withdrawn at predetermined periods and were immediately 
replaced by the same volume of fresh medium. The aliquots, after suitable dilution, were analyzed 
spectrophotometrically at 262 nm [37]. These studies were performed in triplicate for each sample, and the 
average values were reported. 
 
3. Results and discussion 
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Fig.1 Directly observation of obtained drug delivery system. After the tube was taken out of the water bath, the photo was 
taken immediately. (a) 4 °C; (b) 37 °C 
    Pluronic F127 is a polyoxyethylene-polyoxypropylene-polyoxyethylene triblock polymer. At low temperature 
both the PEO and the PPO blocks of the Pluronic F127 are hydrophilic and water soluble forming a transparent 
solution. The triblock copolymers exist as unimers solvated by water. With increasing temperature the PPO 
blocks dehydrate, and F127 form spherical micelles which have a core consists mainly of PPO and the hydrated 
PEO swollen outer shell molecules. Above certain concentration (≥10 wt%) there are micellar clusters due to the 
coalescence of spherical micelles. Finally, a liquid–crystalline phase of disk-like micelles forms [37]. The sol 
transform to a gel with increasing of temperature. At present study the concentration of F127 is 20% (w/v). With 
addition of lidocaine hydrochloride and laponite, the complex system can also transit from a sol to a gel as 
shown in figure .1.At 4 °C, the sol could flow because of its low viscosity, favor for injected. When the 
temperature increased to 37 °C, gel formed and it could not flow again. It can act as a depot for the sustained 
release of drugs. 






















Fig.2 Storage modulus G′ for complex with different concentrations of LP as a function of temperature 
    The temperature dependence of rheological properties of the complex was studied at a range of 4~45 ℃. In 
Fig.2, we plot storage modulus G′ for complex with different concentrations of LP as a function of temperature. 
The storage modulus is low at low temperature but they increase dramatically with increasing temperature as a 
result of the gel forming process. The sol-gel transition temperature of the complex change little with increase of 
LP concentration. But the storage modulus increases with increase in the mass of incorporated LP. Since LP is 
hydrophilic, when the LP concentration exceeds 2% they are able to form a gel at temperatures due to charge-
charge interactions. So the presence of the LP in the complex provides resistance to the shear, hence effectively 
increasing the modulus of the solution [38]. 
    For therapeutic delivery, the size of a nanoplatform plays an important role on its biodistribution. It has been 
reported that nanoparticles with a size around 100 nm are more able to permeate the immature malignant 
neovasculature and accumulate in the tumor site through the enhanced permeation and retention (EPR) effect 
while their uptake by the reticuloendothelial system (RES) occurs in a slower rate [39-41]. Table 1 shows the 
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hydrodynamic diameter (size) of LP, LP/LC, LP/LC/F127 analyzed by dynamic light scattering (DLS) and the 
corresponding ζ-potentials. The Z-average size of LP was32±4 nm, indicating it is well dispersed state in water 
as individual nanodisks [26].The addition of LC resulted in the successful formation of nanocomplexes of LP/LC 
(120 ±5nm), probably through their strong electrostatic interactions[25].The incorporation of F127 appeared to 
further increase the hydrodynamic size of LP/LC, indicating the successful coating of the nanocomplexes, which 
was further confirmed by the less negative ζ-potential of LP/LC/F127(−0.09±0.02 mV) when compared to that 
of LP/LC (−0.62±0.1mV). Pluronic F127 having both PEO and PPO segments is a triblock polymer. The more 
hydrophoic PPO segments have a higher affinity for the LP surface, while the hydrophilic PEO segments 
dangling into solution [33]. 
Table 1 Characterization of LP,LP/LC,LP/LC/F127 nanohybrids in water 
Sample identity Size (nm) Zeta potential (mv) 
LP 32±4 -6.7±0.7 
LP+LC 120±5 -0.62±0.1 
LP+LC+F127 150±7 -0.09±0.02 
    The LP/LC and LP/LC/F127 nanohybids were further characterized by UV-vis spectroscopy, with the spectra 
shown in Fi.3. From their UV-vis spectra , we can see that, for the free LC, LP/LC and LP/LC/F127 
nanohybrids, there is an absorption peak at around 262 nm, which is absent in LP/F127 spectra, indicating the 
successful loading of LC in the nanohybrids [37]. 





























Fig.3 UV−vis spectra of LC, LP/LC, LP/LC/F127and LP/F127 
    At phosphate buffer pH=7.4, the release of pure LC was ~77% in 2.5 h and 81% up to 25 h (Fig. 4). In the 
case of LC/F127, and LC/LP/F127, 44% and 27% LC were released within 5h. The maximum amount of LC 
released was 54% and 34.5% up to 25 h. At present temperature and concentration, F127 can form gel. The 
increase in solution viscosity reduces the lidocaine release rate because drug diffusion through the gel matrix is 
prolonged. With addition of LP, LC can absorb to LP through strong electrostatic interaction. At the same time, 
LP can also increase the viscosity of the solution. So the release rate of lidocaine was slowest for LC/LP/F127 
solution. Therefore, compounding of LC/F127 with LP had a desirable effect on the delivery of LC. The delivery 




    In summary, we develop a novel thermosensitive local drug release system which was prepared by 
incorporation of biocompatible nanoclay laponite into pluronic F127 solution. LP can form nanohydrbid with LC 
through strong electrostatic interaction and increase the viscosity of the solution. Pluronic F127 can form gel 
with increase of temperature and also increase the viscosity of the solution. So the drug delivery can be 
controlled. The combination of LP and F127 may be useful for the controlled delivery of other drugs. 
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Fig.5 Possible sol-gel transition and LC release mechanism of LP/LC/F127 systems. (a) 4 °C; (b) 37 °C; (c) 37 °C, LC 
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